146 related articles for article (PubMed ID: 37570864)
1. Synthesis and Characterization of Methoxy-Exfoliated Montmorillonite Nanosheets as Potential Carriers of 5-Fluorouracil Drug with Enhanced Loading, Release, and Cytotoxicity Properties.
Alqahtani MD; Bin Jumah MN; Al-Hashimi A; Allam AA; Abukhadra MR; Bellucci S
Molecules; 2023 Aug; 28(15):. PubMed ID: 37570864
[TBL] [Abstract][Full Text] [Related]
2. Insights into the Effect of Chitosan and β-Cyclodextrin Hybridization of Zeolite-A on Its Physicochemical and Cytotoxic Properties as a Bio-Carrier for 5-Fluorouracil: Equilibrium and Release Kinetics Studies.
Alqahtani MD; Bin Jumah MN; AlZahrani SA; Allam AA; Abukhadra MR; Bellucci S
Molecules; 2023 Jul; 28(14):. PubMed ID: 37513298
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Characterization of β-Cyclodextrin-Hybridized Exfoliated Kaolinite Single Nanosheets as Potential Carriers of Oxaliplatin with Enhanced Loading, Release, and Cytotoxic Properties.
Alqahtani MD; Nasser N; Bin Jumah MN; AlZahrani SA; Allam AA; Abukhadra MR; Bellucci S
Materials (Basel); 2023 Jul; 16(14):. PubMed ID: 37512232
[TBL] [Abstract][Full Text] [Related]
4. Insight into the Morphological Properties of Nano-Kaolinite (Nanoscrolls and Nanosheets) on Its Qualification as Delivery Structure of Oxaliplatin: Loading, Release, and Kinetic Studies.
Alqahtani MD; Nasser N; Bin Jumah MN; AlZahrani SA; Allam AA; Abukhadra MR; Bellucci S
Molecules; 2023 Jul; 28(13):. PubMed ID: 37446820
[TBL] [Abstract][Full Text] [Related]
5. Facile synthesis of bentonite/biopolymer composites as low-cost carriers for 5-fluorouracil drug; equilibrium studies and pharmacokinetic behavior.
Abukhadra MR; Refay NM; El-Sherbeeny AM; Mostafa AM; Elmeligy MA
Int J Biol Macromol; 2019 Dec; 141():721-731. PubMed ID: 31505207
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Chitosan-Hybridized Diatomite as Potential Delivery Systems of Oxaliplatin and 5-Fluorouracil Drugs: Equilibrium and Release Kinetics.
Alfassam HE; Othman SI; Bin Jumah MN; Al-Waili MA; Allam AA; Al Zoubi W; Abukhadra MR
ACS Omega; 2023 Oct; 8(41):38330-38344. PubMed ID: 37867674
[TBL] [Abstract][Full Text] [Related]
7. Insight into the Loading Properties of Na
Sayed MA; El-Zeiny HM; Khim JS; Ajarem JS; Allam AA; Abukhadra MR
ACS Omega; 2022 Mar; 7(8):6991-7001. PubMed ID: 35252690
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and Characterization of Mg-Hydroxyapatite and Its β-Cyclodextrin Composite as Enhanced Bio-Carrier of 5-Fluorouracil Drug; Equilibrium and Release Kinetics.
Abukhadra MR; Okasha AT; Al Othman SI; Alfassam HE; Alenazi NA; AlHammadi AA; Allam AA
ACS Omega; 2023 Aug; 8(33):30247-30261. PubMed ID: 37636978
[TBL] [Abstract][Full Text] [Related]
9. Enhanced Retention of Cd(II) by Exfoliated Bentonite and Its Methoxy Form: Steric and Energetic Studies.
Abukhadra MR; Nasser N; El-Sherbeeny AM; Al Zoubi W
ACS Omega; 2024 Mar; 9(10):11534-11550. PubMed ID: 38496923
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and characterization of cellulose functionalized zeolitic diatomite as an enhanced carrier of oxaliplatin drug; loading, release, and cytotoxicity.
Alfassam HE; Ashraf MT; Al Othman SI; Al-Waili MA; Allam AA; Abukhadra MR
Int J Biol Macromol; 2023 Apr; 235():123825. PubMed ID: 36828091
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and characterization of chitosan hybridized zinc phosphate/hydroxyapatite core shell nanostructure and its potentiality as delivery system of oxaliplatin drug.
Sayed IR; Alfassam HE; El-Sayed MI; Abd El-Gaied IM; Allam AA; Abukhadra MR
Int J Biol Macromol; 2024 Jan; 254(Pt 1):127734. PubMed ID: 37913876
[TBL] [Abstract][Full Text] [Related]
12. Insight into the Loading and Release Properties of MCM-48/Biopolymer Composites as Carriers for 5-Fluorouracil: Equilibrium Modeling and Pharmacokinetic Studies.
Abukhadra MR; Refay NM; El-Sherbeeny AM; El-Meligy MA
ACS Omega; 2020 May; 5(20):11745-11755. PubMed ID: 32478266
[TBL] [Abstract][Full Text] [Related]
13. A study of purified montmorillonite intercalated with 5-fluorouracil as drug carrier.
Jian CH; Lin FH; Lee YH
Biomed Sci Instrum; 2000; 36():391-6. PubMed ID: 10834264
[TBL] [Abstract][Full Text] [Related]
14. Insight into the Technical Qualification of the Sonocogreen CaO/Clinoptilolite Nanocomposite (CaO
Abukhadra MR; Adlii A; Khim JS; Ajarem JS; Allam AA
ACS Omega; 2021 Nov; 6(47):31982-31992. PubMed ID: 34870021
[TBL] [Abstract][Full Text] [Related]
15. Selective Loading and Prolonged Release of 5-Fluorouracil in the Nanoconfined Interlayer Space of Montmorillonite.
Tan D; Li Y; Zhang Z; Sun S; Sun H; Li B
J Nanosci Nanotechnol; 2021 Jan; 21(1):781-787. PubMed ID: 33213679
[TBL] [Abstract][Full Text] [Related]
16. Insight into chitosan/zeolite-A nanocomposite as an advanced carrier for levofloxacin and its anti-inflammatory properties; loading, release, and anti-inflammatory studies.
Mostafa M; El-Meligy MA; Sharaf M; Soliman AT; AbuKhadra MR
Int J Biol Macromol; 2021 May; 179():206-216. PubMed ID: 33675827
[TBL] [Abstract][Full Text] [Related]
17. Research on 5-fluorouracil as a drug carrier materials with its in vitro release properties on organic modified magadiite.
Ge M; Tang W; Du M; Liang G; Hu G; Jahangir Alam SM
Eur J Pharm Sci; 2019 Mar; 130():44-53. PubMed ID: 30660800
[TBL] [Abstract][Full Text] [Related]
18. Insight into the Loading and Release Properties of an Exfoliated Kaolinite/Cellulose Fiber (EXK/CF) Composite as a Carrier for Oxaliplatin Drug: Cytotoxicity and Release Kinetics.
Tian L; Abukhadra MR; Mohamed AS; Nadeem A; Ahmad SF; Ibrahim KE
ACS Omega; 2020 Aug; 5(30):19165-19173. PubMed ID: 32775918
[TBL] [Abstract][Full Text] [Related]
19. A study of purified montmorillonite intercalated with 5-fluorouracil as drug carrier.
Lin FH; Lee YH; Jian CH; Wong JM; Shieh MJ; Wang CY
Biomaterials; 2002 May; 23(9):1981-7. PubMed ID: 11996039
[TBL] [Abstract][Full Text] [Related]
20. Characterization of chitosan- and β-cyclodextrin-modified forms of magnesium-doped hydroxyapatites as enhanced carriers for levofloxacin: loading, release, and anti-inflammatory properties.
Bin Jumah MN; Al Othman SI; Alomari AA; Allam AA; Abukhadra MR
RSC Adv; 2024 May; 14(24):16991-17007. PubMed ID: 38799215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
